RELATIONSHIP BETWEEN TIME OF TREATMENT OF ACUTE HERPES-ZOSTER WITH SYMPATHETIC BLOCKADE AND PREVENTION OF POSTHERPETIC NEURALGIA - CLINICALSUPPORT FOR A NEW THEORY OF THE MECHANISM BY WHICH SYMPATHETIC BLOCKADE PROVIDES THERAPEUTIC BENEFIT
Ap. Winnie et Pw. Hartwell, RELATIONSHIP BETWEEN TIME OF TREATMENT OF ACUTE HERPES-ZOSTER WITH SYMPATHETIC BLOCKADE AND PREVENTION OF POSTHERPETIC NEURALGIA - CLINICALSUPPORT FOR A NEW THEORY OF THE MECHANISM BY WHICH SYMPATHETIC BLOCKADE PROVIDES THERAPEUTIC BENEFIT, Regional anesthesia, 18(5), 1993, pp. 277-282
Background and Objectives. Since Rosenak's original report more than 5
0 years ago as to the efficacy of sympathetic blocks in terminating ac
ute herpes zoster, many investigators have reported that a more import
ant benefit of this form of therapy is the prevention of post-herpetic
neuralgia. However, most of these reports have indicated that sympath
etic blocks are effective in preventing post-herpetic neuralgia only i
f applied soon after the onset of the acute phase of the disease; in f
act, if applied too late, this form of therapy failed to prevent the d
evelopment of post-herpetic neuralgia. The present study was carried o
ut to determine more precisely the relationship between the time of tr
eatment of acute herpes zoster and the prevention of post-herpetic neu
ralgia and to attempt to correlate this time with the authors' previou
sly published theory on the mechanism by which sympathetic blocks prov
ide the therapeutic benefit. Methods. The present study was a retrospe
ctive review of 122 patients treated at variable intervals after the o
nset of acute herpes zoster. Data tabulated included the duration of s
ymptoms at the time of treatment, the number of sympathetic blocks req
uired to provide relief, and the efficacy of the sympathetic blockade
in terminating the acute phase of herpes zoster and then preventing th
e development of postherpetic neuralgia. Result. According to the data
obtained in this retrospective study, sympathetic blocks terminated t
he pain of acute herpes zoster and prevented or relieved postherpetic
neuralgia in more than 80% of patients treated within 2 months of the
onset of the acute phase of the disease, after which time the success
rate decreased drastically. Conclusion. Sympathetic blockade applied w
ithin the first 2 months after the onset of acute herpes zoster termin
ated the acute phase of the disease, probably by restoring intraneural
blood flow, thus preventing the death of the large fibers and avoidin
g the development of post-herpetic neuralgia. If sympathetic blocks we
re to be carried out after 2 months, the damage to the large fibers wo
uld be irreversible, and this therapeutic modality would not be able t
o prevent the development of post-herpetic neuralgia.